The role of color Doppler and staging biopsies in prostate cancer detection

Urology

Volumn 49, Issue 3 SUPPL., 1997, Pages 31-34

  Bree, Robert L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY TECHNIQUE; CANCER INVASION; CANCER STAGING; COLOR ULTRASOUND FLOWMETRY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HUMAN; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

BIOPSY; HUMANS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0030999912     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00166-0     Document Type: Conference Paper

References (28)

1. Austenfeld MS: Preoperative estimate of extent of disease in T1c: how well can we predict? Semin Urol Oncol 13: 176-180, 1995.
2. Epstein JI, Walsh PC, Carmichael M, and Brendler CB: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tlc) prostate cancer. JAMA 271: 368-374, 1994.
3. Ohori M, Wheeler TM, Kattan MW, Goto Y, and Scardino PT: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154: 1818-1824, 1995.
4. Catalona WJ, Smith DS, and Ratliff TL, et al: Detection of organ-confined prostate cancer is increased through prostate specific antigen based screening. JAMA 270: 948-954, 1993.
5. D'Amico AV, Whittington R, and Malkowicz SB, et al: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154: 131-138, 1995.
6. D'Amico AV, Whittington R, and Malkowicz SB, et al: A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 30: 293-302, 1994.
7. Flanigan RC, Catalona WJ, and Richie JP, et al: Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol 152: 1506-1509, 1994.
8. Huch Böni RA, Boner JA, and Debatin JF, et al: Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 50: 593-600, 1995.
9. Jager GJ, Ruijter ETG, and van de Kaa CA, et al: Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. Am J Roentgenol 166: 845-852, 1996.
10. Narayan P, Gajendran V, and Taylor SP, et al: The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 46: 205-212, 1995.
11. Partin AW, Yoo J, and Carter HB, et al: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150: 110-114, 1993.
12. Ravery V, Boccon-Gibod LA, and Dauge-Geffroy MC, et al: Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 44: 371-376, 1994.
13. Terris MK, Freiha FS, and McNeal JE, et al: Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 146: 78-84, 1991.
14. Ellis WJ, and Brawer MK: The significance of isoechoic prostatic carcinoma. J Urol 152: 2304-2307, 1994.
15. Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, and Oesterling JE: The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 275: 288-294, 1996.
16. Peller PA, Young DC, Marmaduke DP, Marsh WL, and Badalament RA: Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer 75: 530-538, 1995.
17. Kelly IMG, Lees WR, and Rickards D: Prostate cancer and the role of color Doppler US. Radiology 189: 153-156, 1993.
18. Patel U, and Rickards D: The diagnostic value of color Doppler flow in the peripheral zone of the prostate with histological correlation. Br J Urol 74: 590-595, 1994.
19. Rifkin MD, Sudakoff GS, and Alexander AA: Prostate: techniques, results and potential applications of color Doppler US-scanning. Radiology 186: 509-513, 1993.
20. Newman JS, Bree RL, and Rubin JM: Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195: 86-90, 1995.
21. Decarvalho V, and Kuligowska E: The role of color Doppler for improving the detection of cancer in the isoechoic prostate gland. Presented at the Annual Meeting of the American Institute of Ultrasound in Medicine. New York, March, 1996.
22. Littrup PJ, Klein RM, Gross ML, Sparschu RA, Segel MC, and Zingas AP: Color Doppler guides prostate biopsies of higher grade cancers: racial implications. Presented at the Annual Meeting of the American Institute of Ultrasound in Medicine. New York, March, 1996.
23. Bigler SA, Deering RE, and Brawer MK: A comparison of microscopic vascularity in benign and malignant prostate disease. Hum Pathol 24: 220-226, 1993.
24. Brawer MK, Deering RE, Brown M, Preston SD, and Bigler SA: Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 73: 678-687, 1994.
25. Louvar E, Littrup PJ, Yu L, and Grignon DJ: The pathophysiology of increased color Doppler flow in the prostate. Presented at the Annual Meeting of the American Institute of Ultrasound in Medicine. New York, March, 1996.
26. Bastacky SI, Walsh PC, and Epstein JI: Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 17: 336-341, 1993.
27. Stock RG, Stone NN, Ianuzzi C, and Unger P: Seminal vesicle biopsy and laparoscopic pelvis lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Radiat Oncol Biol Phys, 33: 815-821, 1995.
28. Vallancien G, Prapotnich D, Veillon B, Brisset JM, and André-Bougaran J: Seminal vesicle biopsies in the preoperative staging of prostatic cancer. Eur Urol 19: 196-200, 1991.